All News
STAT+: Top drug regulator is retiring as FDA departures mount
The top drug regulator at the FDA is retiring in July, as departures of senior leaders mount.
Read MoreSTAT+: Compass psilocybin therapy shown to be effective in largest-ever study in depression
Compass Pathways said Monday it achieved its primary endpoint in an early readout from the largest-ever study of psilocybin for treatment-resistant depression.
Read MoreHHS Probes Major Health System; FDA Nausea Med Warning; Reveal Presidents' Health?
(MedPage Today) -- Note that some links may require registration or subscription.
Read MoreSTAT+: MAHA eyes tolerance as alcohol-related harms emerge
And more health news stories you need to start your week.
Read MoreSTAT+: Pharmalittle: We’re reading about Novo ending Hims deal, FDA transparency, and more
Novo Nordisk is halting its collaboration with Hims & Hers Health over the sale of weight loss drugs
Read MoreSTAT+: Eli Lilly drug preserves lean mass in patients losing weight on Wegovy
Some doctors are concerned that patients taking weight loss drugs like Wegovy may be losing too much lean mass. A combination therapy might change that.
Read MoreSTAT+: Novo Nordisk ends deal with Hims due to compounding concerns with obesity drugs
Novo Nordisk is ending a deal with telehealth company Hims & Hers, saying Monday that Hims has been engaging in “illegal mass compounding” of GLP-1 obesity treatments and “deceptive marketi
Read MoreCardiac care in tier 2 & 3 cities: The road ahead
India is currently facing an unprecedented cardiac crisis, one that’s no longer limited to its metro cities.
Read MoreIndira IVF acquires stake in Banker IVF to expand fertility services in Gujarat
The partnership brings together over 30 years of clinical expertise and expands Indira IVF’s footprint across Ahmedabad and key cities in the state
Read MoreMahajan Imaging reports 29% of young adults show early lung damage in routine CT scans
Internal review of over 4,000 scans highlights structural abnormalities in lungs of individuals in their 20s and 30s, raising concerns over urban respiratory health
Read More